Maria Pia Foschino Barbaro
Overview
Explore the profile of Maria Pia Foschino Barbaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
962
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pelaia C, Crimi C, Benfante A, Caiaffa M, Campisi R, Candia C, et al.
Respirology
. 2024 Jun;
29(10):869-879.
PMID: 38847185
Background And Objective: Several randomized controlled trials (RCTs) have shown that benralizumab is characterized by a good profile of efficacy and safety, thereby being potentially able to elicit clinical remission...
12.
Tondo P, Hoxhallari A, Lacedonia D, Magaletti P, Sabato R, Foschino Barbaro M, et al.
Sleep Breath
. 2024 Apr;
28(4):1761-1765.
PMID: 38627338
Purpose: Asthma, obstructive sleep apnea (OSA), rhinosinusitis, and esophageal reflux are conditions that may overlap, forming a syndrome known as CORE. Whenever clinical remission of severe asthma (SA) is not...
13.
Resta E, Quarato C, Scioscia G, Cuscianna E, Tondo P, Mansueto G, et al.
Ann Ig
. 2024 Mar;
36(5):597-613.
PMID: 38436080
Background: Post COVID-19 syndrome is a frequent disabling outcome, leading to a delay in social reintegration and return to working life. Study Design: This was a prospective observational cohort study....
14.
Soccio P, Moriondo G, DAlessandro M, Scioscia G, Bergantini L, Gangi S, et al.
Biomedicines
. 2024 Feb;
12(2).
PMID: 38397871
Interstitial lung diseases (ILDs) encompass a diverse group of disorders affecting the lung interstitium, leading to inflammation, fibrosis, and impaired respiratory function. Currently, the identification of new diagnostic and prognostic...
15.
Quarato C, Tondo P, Lacedonia D, Soccio P, Fuso P, Sabato E, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202298
Nowadays, highly selective biological drugs offer the possibility of treating severe type 2 asthma. However, in the real-life setting, it is crucial to confirm the validity of the chosen biological...
16.
Soccio P, Moriondo G, Lacedonia D, Tondo P, Pescatore D, Quarato C, et al.
Biomolecules
. 2023 Oct;
13(10).
PMID: 37892224
Severe asthma (SA) is a chronic inflammatory disease of the airways. Due to the extreme heterogeneity of symptoms, new biomarkers are currently needed. MiRNAs are non-coding RNAs that negatively regulate...
17.
Soccio P, Moriondo G, Scioscia G, Leo V, Tondo P, Salerno L, et al.
BMC Pulm Med
. 2023 Oct;
23(1):407.
PMID: 37884953
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with unknown etiology. To date, the identification of new diagnostic, prognostic and progression biomarkers of IPF turns out to...
18.
Tondo P, Scioscia G, Sabato R, Leccisotti R, Hoxhallari A, Sorangelo S, et al.
Sleep Med
. 2023 Oct;
112:96-103.
PMID: 37837825
Background: Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are two chronic diseases that afflict many individuals worldwide with negative effects on health that may overlap in...
19.
Moriondo G, Soccio P, Minoves M, Scioscia G, Tondo P, Foschino Barbaro M, et al.
Arch Bronconeumol
. 2023 Jul;
59(10):629-637.
PMID: 37517933
Introduction: There is still a debate for the link between obstructive sleep apnoea (OSA) and cancer. The mechanisms underlying this causality are poorly understood. Several miRNAs are involved in cancer...
20.
Scioscia G, Tondo P, Nolasco S, Pelaia C, Carpagnano G, Caiaffa M, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445397
Background: Mepolizumab and benralizumab are monoclonal antibodies directed against anti-IL-5 and anti-IL5R, respectively, and their use reduces the exacerbation rate and maintains oral corticosteroid requirements in severe eosinophilic asthma. Previous...